Terms: = Pancreatic cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919
21 results:
1. PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway.
Wu D; Chen W; Yang Y; Qin Y; Zu G; Zhang Y; An Y; Sun D; Xu X; Chen X
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(9):1393-1403. PubMed ID: 37337632
[TBL] [Abstract] [Full Text] [Related]
2. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
Wan JL; Wang B; Wu ML; Li J; Gong RM; Song LN; Zhang HS; Zhu GQ; Chen SP; Cai JL; Xing XX; Wang YD; Yang Y; Cai CZ; Huang R; Liu H; Dai Z
Cancer Lett; 2022 Aug; 541():215750. PubMed ID: 35609735
[TBL] [Abstract] [Full Text] [Related]
3. "Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms.
Mattiolo P; Mafficini A; Lawlor RT; Marchegiani G; Malleo G; Pea A; Salvia R; Piccoli P; Sciammarella C; Santonicco N; Parisi A; Silvestris N; Milella M; Adsay V; Scarpa A; Luchini C
Virchows Arch; 2022 Jul; 481(1):41-47. PubMed ID: 35359182
[TBL] [Abstract] [Full Text] [Related]
4. Combined evaluation of proliferation and apoptosis to calculate IC
Ekici Y; Yilmaz A; Kucuksezer UC; Gazioglu SB; Yamalioglu ZD; Gurol AO; Linn T; Tuncer FN
Med Oncol; 2021 Aug; 38(9):109. PubMed ID: 34357487
[TBL] [Abstract] [Full Text] [Related]
5. A limited panel of INSM1 and lef1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
Guo W; Farzaneh T; Lee W; Nael A; Li X; Chandan VS
Pathol Res Pract; 2021 Jul; 223():153462. PubMed ID: 34048981
[TBL] [Abstract] [Full Text] [Related]
6. [Diagnostic Utility of lef1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
Farzaneh T; Nowroozizadeh B; Han M; Lee W
Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
[TBL] [Abstract] [Full Text] [Related]
7. Long noncoding RNA lef1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract] [Full Text] [Related]
8. Rosai-Dorfman Disease and Exocrine pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
[TBL] [Abstract] [Full Text] [Related]
9. Lymphoid Enhancer Binding Factor 1 (lef1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA lef1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract] [Full Text] [Related]
11. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract] [Full Text] [Related]
12. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H
Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138
[TBL] [Abstract] [Full Text] [Related]
13. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
14. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.
Keutgen XM; Kumar S; Gara SK; Boufraqech M; Agarwal S; Hruban RH; Nilubol N; Quezado M; Finney R; Cam M; Kebebew E
Cancer; 2018 Feb; 124(3):636-647. PubMed ID: 29149451
[TBL] [Abstract] [Full Text] [Related]
16. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.
Garg B; Giri B; Majumder K; Dudeja V; Banerjee S; Saluja A
Cancer Lett; 2017 Mar; 388():64-72. PubMed ID: 27919787
[TBL] [Abstract] [Full Text] [Related]
18. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
Kermanshahi TR; Jayachandran P; Chang DT; Pai R
Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of lymphoid enhancer-binding factor 1 (lef1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract] [Full Text] [Related]
20. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.
Watson RL; Spalding AC; Zielske SP; Morgan M; Kim AC; Bommer GT; Eldar-Finkelman H; Giordano T; Fearon ER; Hammer GD; Lawrence TS; Ben-Josef E
Neoplasia; 2010 May; 12(5):357-65. PubMed ID: 20454507
[TBL] [Abstract] [Full Text] [Related]
[Next]
